Managing

 

Continuing Education

This module has been approved for the following:

CME	2.25
CNE	2.2
CEU	0.2

Following completion of all case studies in a module, please go to www.cdc.gov/TCEOnline to evaluate the course and receive a certificate of completion. You can also print an ongoing transcript of all your TCEOnline CE activities to secure continuing education hours.  You must complete all case studies in this module to receive continuing education hours; you can take them at once or at different times.

Detailed instructions on how to obtain CE hours is provided in the “Course Information” link in the top right corner in each case.

Accreditation Statements

• CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Centers for Disease Control and Prevention designates this online educational activity for a maximum of 2.25 AMA PRA Category 1 Credits™.  Non-physicians may receive a certificate of participation.

• CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation. This activity provides 2.2 contact hours.

                                                       

• CEU: The CDC has been approved as an Authorized Provider by the International Association for Continuing Education and Training (IACET), 1760 Old Meadow Road, Suite 500, McLean, VA 22102.  The CDC is authorized by IACET to offer 0.2 ANSI/IACET CEU's for this program.

Disclosure

CDC, our planners, and our content experts wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.

Content will not include any discussion of the unlabeled use of a product or a product under investigational use with the exception of Dr. Bridgemohan, Dr. Huffman, Dr. Farrell, and Dr. Tang’s modules on Early Intervention and Education and Treatments for Autism Spectrum Disorders. These modules discuss many of the medications used to help with maladaptive behaviors and psychiatric co-morbidities prevalent in children with ASDs which are used off-label. A primary care provider may encounter a child with an ASD on one or more of these medications in the course of his or her practice. It is important to be aware of side-effect profiles, contraindications, and health monitoring in children on these medications. While side effects should be monitored by the prescriber, the primary care provider also needs to make sure these are monitored, be aware of the possible drug interactions with other medications prescribed, and know the side effects so they can be considered in the differential diagnosis of symptoms brought to the primary care office for treatment. This case educates users on medications others may be prescribing for their patients, so they can understand and best manage their patient’s overall health and well being. The primary care provider should be aware of which are FDA approved and which are not.

CDC does not accept commercial support.